Heart of the Matter
Heart of the Matter
Entresto, inpatient therapy, and surrogate markers
One overriding factor behind the slow uptake of Entresto for heart failure may be the cost of the drug compared to enalapril.
Heart of the Matter
Who’s increasing health care costs? Not us!
Community leadership has been minimized, and where it exists, it is under constant pressure to make a profit.
Heart of the Matter
Medical ethics and economics
It’s up to physicians to build an ethical wall between interests in clinical research.
Heart of the Matter
The end of aspirin for primary prevention
Heart of the Matter
Heart cell transplant rejections
Piero Anversa’s fraudulent research led to an NIH study in humans that is still ongoing.
Heart of the Matter
I’M NOT A PROVIDER
Health care isn’t a commodity, and patients aren’t customers. We’re not talking about shoes.
Commentary
‘If this is an emergency, call 911’
Or, don’t even try speaking directly your doctor.
Heart of the Matter
Beta-blocker therapy post AMI
Stick with beta-blocker therapy until evidence shows why not to use it.
Commentary
CMS clinical trials raise cardiac mortality
Health agencies should take their cues from randomized clinical trial designs to avoid unintended consequences.
Heart of the Matter
PCI or CABG in the high-risk patient
The recent report from the SYNTAX trials should give pause to our interventionalist colleagues embarking on multiple angioplasty and stenting...